PDL BioPharma (PDLI) Income Statement

Click line-items for a historical chart and %

Royalties	14.96M
License and other	-127K
Total revenues	53.64M
General and administrative expenses	10.4M
Operating income	32.66M
Loss on retirement or conversion of convertible notes
Interest and other income
Interest and other expense	-4.51M
Total non-operating expense, net	-4.35M
Income before income taxes	28.3M
Income tax expense	14.4M
Net income	13.91M
Net income per basic share (in dollars per share)	0.08
Net income per diluted share (in dollars per share)	0.08
Cash dividends declared per common share (in dollars per share)	0
Shares used to compute net income per basic share (in shares)	163.86M
Shares used to compute net income per diluted share (in shares)	164.29M

Entities mentioned with PDLI

View All Entities